Last --
Change Today 0.00 / 0.00%
Volume 0.0
801 On Other Exchanges
Symbol
Exchange
801 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

golden meditech holdings ltd (801) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GOLDEN MEDITECH HOLDINGS LTD (801)

Related News

No related news articles were found.

golden meditech holdings ltd (801) Related Businessweek News

No Related Businessweek News Found

golden meditech holdings ltd (801) Details

Golden Meditech Holdings Limited, an investment holding company, operates as an integrated healthcare enterprise in the People’s Republic of China (PRC). It operates through five segments: Medical Devices, Cord Blood Storage, Hospital Management, Medical Insurance Administration, and Chinese Herbal Medicine. The Medical Devices segment develops, manufactures, and sells medical devices and medical accessories. This segment offers blood related medical devices comprising Autologous Blood Recovery System and its consumables; and distributes AXP System, an automated device for the process of extracting blood stem cells from cord blood. The Cord Blood Bank segment provides cord blood stem cell examination, processing, separation, storage, and other related services. The Hospital Management segment offers management services to hospitals. It also provides premium healthcare services; and operates two hospitals, which are specialized primarily in hematology. The Medical Insurance Administration segment offers medical insurance administration services. It provides claim processing and bill settlement services to medical insurance companies, hospitals, and policy holders. The Chinese Herbal Medicine segment is involved in the research, development, manufacture, and sale of Chinese herbal medicines. The company was formerly known as Golden Meditech Company Limited and changed its name to Golden Meditech Holdings Limited in March 2010. Golden Meditech Holdings Limited was incorporated in 2001 and is headquartered in Beijing, the People’s Republic of China.

1,680 Employees
Last Reported Date: 06/24/14
Founded in 2001

golden meditech holdings ltd (801) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, C...
Total Annual Compensation: $6.6M
Chief Operating Officer and Executive Directo...
Total Annual Compensation: $6.7M
Qualified Accountant, Company Secretary and E...
Total Annual Compensation: $6.6M
Executive Director, Member of Executive Commi...
Total Annual Compensation: $1.2M
Compensation as of Fiscal Year 2013.

golden meditech holdings ltd (801) Key Developments

Golden Meditech Holdings Limited Recommends Final Dividend for the Year Ended March 31, 2014; Recommends Special Dividend; Announces Consolidated Financial Results for the Year Ended March 31, 2014

The board of directors of the Golden Meditech Holdings Limited announced that at their meeting held on June 24, 2014, has recommended a final dividend of 2.6 cents per share against 1.3 cents per share of last year to acknowledge the continuous support and trust from shareholders. The final dividend is subject to the approval of the forthcoming annual general meeting to be held on September 19, 2014. The board also recommended the payment of a special dividend of HKD 0.03 per each consolidated share payable to the shareholders whose names appeared on the register of members at the close of business on June 10, 2014. The company also announced consolidated financial results for the year ended March 31, 2014. For the year, the company reported turnover of HKD 1,085,068,000 against HKD 1,079,062,000 a year ago. Loss from operations was HKD 303,001,000 against profit from operations of HKD 283,461,000 a year ago. Such fluctuation was largely attributable to the other net loss and impairment losses recorded by the Group during the year. Excluding such losses, the Group recorded adjusted operating profit of HKD 268,744,000, represented a 5.4% decrease as compared to the previous reporting period. Loss before tax was HKD 744,024,000 against profit before tax of HKD 298,731,000 a year ago. Loss after tax was HKD 712,864,000 against profit after tax of HKD 208,767,000 a year ago. Adjusted profit after tax was HKD 141.133 million against HKD 227.719 million a year ago. Loss attributable to equity shareholders was HKD 429,081,000 or 33.6 cents per basic and diluted share against profit attributable to equity shareholders of HKD 135,660,000 or 11.2 cents per diluted share a year ago. Adjusted attributable to equity shareholders was HKD 86.464 million or 6.8 cents per basic share against HKD 106.062 million or 9.9 cents per basic share a year ago. Net cash generated from operating activities was HKD 801,628,000 against HKD 731,908,000 a year ago. Payment for the acquisition of property, plant and equipment was HKD 295,775,000 against HKD 552,734,000 a year ago. Such fluctuation was mainly attributable to various one-off losses and fair value losses on financial assets and financial liabilities at fair value through profit or loss recorded during the year. Excluding such losses, adjusted profit attributable to equity shareholders of the company was HKD 86,464,000, representing a 18.5% decrease as compared to the previous reporting period.

Golden Meditech Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended March 31, 2014

Golden Meditech Holdings Limited provided consolidated earnings guidance for the year ended March 31, 2014. For the period, the company based on the preliminary review of the unaudited consolidated management accounts of the group, it is expected that the group will record a loss of approximately HKD 713 million compared to a profit of approximately HKD 209 million recorded in the corresponding period.

Golden Meditech Holdings Limited Provides Earnings Guidance for the Year Ended March 31, 2014

Golden Meditech Holdings Limited provided earnings guidance for the year ended March 31, 2014. The company announced that based on the preliminary review of the unaudited consolidated management accounts of the Group for the year ended March 31, 2014, the Group is expected to record a loss for the year ended March 31, 2014, as compared to a profit recorded for the corresponding period in 2013. Such substantial increase in loss is mainly attributable to (i) the increase in fair value loss as a result of the accounting treatment for certain convertible notes, as compared to the corresponding period last year; (ii) mark-to-market loss as a result of the decline in market values of certain security investments, as opposed to a gain recorded in the corresponding period last year; and (iii) impairment losses on certain financial assets, intangible assets and interests in a joint venture, while no such loss was recorded in the corresponding period last year. The losses as stated above were recognised in compliance with the currently applicable accounting standards of the Group. Except for the fair value loss as a result of the early redemption of the convertible notes held by the company, all of them are non-cash in nature and have no effect on the cash flows of the Group for the current reporting period. The Board considers that, excluding the above mentioned gains and losses, the results from the Group's underlying operating businesses for the year ended 31 March 2014 should not show a significant fluctuation from that of the corresponding period in 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
801:HK $1.24 HKD -0.01

801 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 801.
View Industry Companies
 

Industry Analysis

801

Industry Average

Valuation 801 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 0.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GOLDEN MEDITECH HOLDINGS LTD, please visit www.goldenmeditech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.